Suchergebnisse - "Dufour, Annika"

PubPharm (7)

1

Sequential high-dose cytarabine and mitoxantrone (S-HAM) versus standard double induction in acute myeloid leukemia-a phase 3 study

enthalten in: Leukemia | 2018

von Braess, J. | Amler, S. | Kreuzer, K. | +43

2

Spectrum and prognostic relevance of driver gene mutations in acute myeloid leukemia

enthalten in: Blood | 2016

von Metzeler, K. | Herold, T. | Rothenberg-Thurley, M. | +23

3

Long-term follow-up of cytogenetically normal CEBPA-mutated AML

enthalten in: Journal of hematology & oncology | 2014

von Pastore, F. | Kling, D. | Hoster, E. | +10

4

PTK2 expression and immunochemotherapy outcome in chronic lymphocytic leukemia

enthalten in: Blood | 2014

von Weisser, M. | Yeh, R. | Duchateau-Nguyen, G. | +29

5

Combined molecular and clinical prognostic index for relapse and survival in cytogenetically normal acute myeloid leukemia

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2014

von Pastore, F. | Dufour, A. | Benthaus, T. | +23

6

Inactivation of TP53 correlates with disease progression and low miR-34a expression in previously treated chronic lymphocytic leukemia patients

enthalten in: Blood | 2013

von Dufour, A. | Palermo, G. | Zellmeier, E. | +24

7

The FLT3ITD mRNA level has a high prognostic impact in NPM1 mutated, but not in NPM1 unmutated, AML with a normal karyotype

enthalten in: Blood | 2012

von Schneider, F. | Hoster, E. | Unterhalt, M. | +17

1
[1]